Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Vertex Pharmaceuticals
Vertex Pharmaceuticals
Vertex’s second try at a rare lung disorder
Vertex’s second try at a rare lung disorder
EP Vantage
Vertex Pharmaceuticals
VX-814
alpha-1 antitrypsin
Flag link:
Vertex is poised for a shopping spree. But it’s still unclear just what might go into their basket — and at least one analyst is getting impatient
Vertex is poised for a shopping spree. But it’s still unclear just what might go into their basket — and at least one analyst is getting impatient
Endpoints
Vertex Pharmaceuticals
M&A
Flag link:
The diabetes 'cure' Vertex acquired in its 2019 Semma buyout? It's headed to the clinic
The diabetes 'cure' Vertex acquired in its 2019 Semma buyout? It's headed to the clinic
Endpoints
Vertex Pharmaceuticals
Semma Therapeutics
M&A
gene therapy
VX-880
type 1 diabetes
Flag link:
Vertex's (VRTX) Trikafta NDA Gets Priority Review by FDA
Vertex's (VRTX) Trikafta NDA Gets Priority Review by FDA
Yahoo/Zacks.com
Vertex Pharmaceuticals
cystic fibrosis
priority revies
FDA
Trikafta
Flag link:
10 key clinical trials to watch in the first half of 2021
10 key clinical trials to watch in the first half of 2021
BioPharma Dive
clinical trials
Novavax
AstraZeneca
JNJ
vaccines
COVID-19
Biomarin
Amgen
Merck
Pfizer
Roche
SAGE Therapeutics
Biogen
Vertex Pharmaceuticals
Flag link:
JPM21: Biogen faces make-or-break year, Vertex mulls deals and Sarepta pitches a silver lining
JPM21: Biogen faces make-or-break year, Vertex mulls deals and Sarepta pitches a silver lining
BioPharma Dive
JPMHC 2021
Biogen
Vertex Pharmaceuticals
Sarepta Therapeutics
Flag link:
Vertex teams up with Skyhawk, leaning on another biotech in bid to diversify
Vertex teams up with Skyhawk, leaning on another biotech in bid to diversify
BioPharma Dive
Vertex Pharmaceuticals
Skyhawk Therapeutics
small molecule drugs
M&A
Flag link:
Red-Hot Biotechs to Take Spotlight at Blood Disorder Meeting
Red-Hot Biotechs to Take Spotlight at Blood Disorder Meeting
Yahoo/Bloomberg
ASH2020
Trillium Therapeutics
CRISPR Therapeutics
Fate Therapeutics
Vertex Pharmaceuticals
Flag link:
Locus Biosciences bags up to $12.1M for CRISPR antibacterial; Old Vertex drug heads to PhIII for dementia
Locus Biosciences bags up to $12.1M for CRISPR antibacterial; Old Vertex drug heads to PhIII for dementia
Endpoints
Locus Biosciences
CARB-X
CRISPR
rUTIs
UTIs
bacteriophage
EIP Pharma
Vertex Pharmaceuticals
dementia
clinical trials
Flag link:
CRISPR and Vertex Release Additional Data for Blood Disease Treatment
CRISPR and Vertex Release Additional Data for Blood Disease Treatment
Motley Fool
CRISPR Therapeutics
CRISPR
Vertex Pharmaceuticals
CTX001
beta thalassemia
sickle cell disease
Flag link:
Vertex Pharmaceuticals (VRTX) Tops Q3 Earnings and Revenue Estimates
Vertex Pharmaceuticals (VRTX) Tops Q3 Earnings and Revenue Estimates
Yahoo/Zacks.com
Vertex Pharmaceuticals
earnings
Flag link:
Vertex urged to address 'fatal inequality' in access to its cystic fibrosis drug
Vertex urged to address 'fatal inequality' in access to its cystic fibrosis drug
Beckers Hospital Review
Vertex Pharmaceuticals
cystic fibrosis
drug pricing
Flag link:
Vertex faces first notable setback as it pushes beyond cystic fibrosis
Vertex faces first notable setback as it pushes beyond cystic fibrosis
BioPharma Dive
Vertex Pharmaceuticals
VX-814
clinical trials
Flag link:
Vertex's Kalydeco Gets FDA Nod for Cystic Fibrosis in Infants
Vertex's Kalydeco Gets FDA Nod for Cystic Fibrosis in Infants
Yahoo/Zacks.com
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Flag link:
Moderna lands $100M upfront in deals with Vertex, Chiesi
Moderna lands $100M upfront in deals with Vertex, Chiesi
Fierce Biotech
Moderna Therapeutics
cystic fibrosis
R&D
Vertex Pharmaceuticals
gene editing
Chiesi
Flag link:
An old Vertex drug gets new life as an Alzheimer's treatment, but human studies still far off
An old Vertex drug gets new life as an Alzheimer's treatment, but human studies still far off
Endpoints
Vertex Pharmaceuticals
Alzheimer's disease
VX-765
Flag link:
Vertex Pharmaceuticals Reports Positive Phase 3 Results in Children for Blockbuster CF Drug
Vertex Pharmaceuticals Reports Positive Phase 3 Results in Children for Blockbuster CF Drug
Motley Fool
Vertex Pharmaceuticals
Trikafta
clinical trials
Flag link:
How Vertex Pharmaceuticals Wowed With Its Q2 Results
How Vertex Pharmaceuticals Wowed With Its Q2 Results
Motley Fool
Vertex Pharmaceuticals
earnings
Flag link:
Vertex : CHMP Grants Positive Opinion For KAFTRIO - KALYDECO In People Ages 12 And Older With CF
Vertex : CHMP Grants Positive Opinion For KAFTRIO - KALYDECO In People Ages 12 And Older With CF
Business Insider
Vertex Pharmaceuticals
Europe
EMA
CHMP
cystic fibrosis
Kalydeco
Kaftrio
Flag link:
CRISPR and Vertex show durability of gene-editing therapy, hoping for one and done treatment
CRISPR and Vertex show durability of gene-editing therapy, hoping for one and done treatment
Fierce Biotech
Vertex Pharmaceuticals
CRISPR Therapeutics
CTX001
gene editing
sickle cell disease
beta thalassemia
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »